Stroke survivors double functional improvement rate with vagus nerve stimulation: study
By
Alicia Lasek
Apr 27, 2021
Vagus nerve stimulation during post-stroke rehabilitation can significantly boost the improvement rate of arm and hand function, a new study finds.
Feds look to OTC drugs for self-treatment of mild, moderate COVID
By
Alicia Lasek
Apr 21, 2021
A large trial is set to study the potential for repurposed, over-the-counter drugs to treat mild-to-moderate COVID-19 symptoms. If found effective, the approval timeline will likely be short, according...
Clinical briefs for Tuesday, April 20
By
Alicia Lasek
Apr 20, 2021
FDA revokes approval for COVID antibody drug; others remain available … Once-a-week insulin treatment equals daily therapy in diabetes study … Two remedesivir drug combo treatments equally effective,...
Older adults who have received J&J need not be concerned: expert
By
Amy Novotney
Apr 20, 2021
Joshua Sharfstein, M.D., vice dean for public health practice and community engagement at Johns Hopkins University, has a message for older adults who have received the Johnson & Johnson COVID-19 vaccine:...
Clinical briefs for Wednesday, April 14
By
Alicia Lasek
Apr 14, 2021
NIH updates monoclonal antibody COVID treatment protocols … Surveyed community pharmacists say vaccine supply is bigger problem than patient reluctance … B.1.1.7 variant more transmissible but does...
An antibody cocktail that halts disease progression in sick COVD-19 patients has been shown to prevent the disease altogether in healthy people who live in close contact with an infected person, the drugmaker...
Clinical briefs for Friday, April 9
By
Alicia Lasek
Apr 09, 2021
Focus shifts to short-stay residents to prevent future COVID-19 outbreaks … U.S. COVID vaccination rates to plateau in April, survey results suggest … U.S. hits COVID shot target; 25% of adults now...
Clinical briefs for Wednesday, April 7
By
Alicia Lasek
Apr 07, 2021
Remote cardiology visits tied to decrease in diagnostic tests, medications … Despite pandemic, less than half of older adults have recorded end-of-life wishes … U.S. COVID case counts continue to rise...
FDA advisers object to Alzheimer’s drug aducanumab ahead of final decision
By
Alicia Lasek
Apr 05, 2021
The experimental Alzheimer’s drug aducanumab is not ready for federal approval in June, advisers to the Food and Drug Administration say in a new JAMA editorial.
Clinical briefs for Thursday, April 1
By
Alicia Lasek
Apr 01, 2021
J&J shipment of 15 million vaccines halted due to manufacturing error … NIH: Preventive treatment slows eye damage in diabetes … Unhealthy gums tied to higher systolic blood pressure in healthy...